RUNX2 and hepatocellular carcinoma: Experiments on HCC cell lines revealed that RUNX2 is associated with EMT and VM processes by regulating the expression of adhesion molecules such as VE-cadherin and galectin-3, which indirectly contribute to tumour cell migration and enhanced metastatic potential [104,116,117].